Call 800 665 0411 to learn about our services

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

New Medical Cannabis Technology Company from Poland joins iCAN: israel-cannabis' Incubator

Cannabinit Produces Cannabis Plant Cells In Vitro


Tel Aviv - October 26, 2018 ( Newswire) iCAN: Israel-Cannabis has partnered with Polish biologist and entrepreneur, Rafał Ślusarczyk, to form Cannabinit, a new company that utilizes revolutionary technology to produce high quality plant cells in vitro. This process eliminates the need to grow a whole plant or the need for a growing facility, at all.

Just days ago, Cannabinit came in First Place in the CannX Medical Cannabis Conference start-up competition which took place in Tel Aviv.

Ślusarczyk, a former manager at the academic business incubator and biologist from the West Pomeranian University of Technology in Poland, devised the novel technique. Compared to greenhouse growing, the process is highly efficient, avoids risk of plant diseases or genetic variations/mutations, and results in controlled, standardized plant extract.

The technology has been successfully used on lavender plants and now Ślusarczyk is working to transfer the technology to the medical cannabis world and bring it to market with the help of iCAN's expertise, global network and reputation.

Cannabinit will join iCAN's portfolio of successfully incubated projects including CMTREX and Yom Chai.

Saul Kaye, CEO and Founder of iCAN said, "I will be mentoring Rafał Ślusarczyk through the EU Science exchange program, Erasmus for Young Entrepreneurs, and am excited about the great potential of his discovery. In contrast to the process of growing cannabis in a greenhouse, we believe that this breakthrough process will lower costs of maintenance and is significantly more efficient. Furthermore, there is no risk of plant diseases and there will be no difficulty in the standardization of the final product, a serious market concern. Controlling the content of the cells in the cannabis plant is a game changer for the developing medical cannabis market. I am thrilled that Cannabinit will join iCAN's incubator portfolio and certain that we will successfully launch this revolutionary technology."

About Cannabinit

Our mission is to bring relief to patients by providing pharmaceuticals based on active substances from medical hemp to the Polish pharmaceutical market and beyond. We will participate in research and development projects aimed at creating innovative medicines, conduct educational activities and promote cannabis treatment. Click on the Cannabinit link for more information.

About iCAN

iCAN is building the global cannabis ecosystem. iCAN identifies and accelerates innovative medical cannabis technologies and creates synergy and cooperation across the industry. iCAN uses its global network and reach to position Israel as the leading medical cannabis tech hub.

This project is seeking seed funding and we invite strategic investors to reach out to

For media inquiries contact Laura Kam at +972-54-806-8613.

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories for Cannabis stocks and Psychedelic Stocks

Buy a cannabis guest post on